Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond
QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes
Patients with underlying heart problems are more than four times as likely to die from COVID-19
The company plans to interface the algorithm into the Atellica Data Manager software in the future
Lab manager Marisa Hildebrandt emphasizes the need for better communication in science and honest product reviews that ‘get past the hype’
Watch this on-demand webinar to gain insights into the design and development pipeline for rapid response solutions
Dr. Tullia Bruno shares her multi-omics approach to investigating the role of B cells and tertiary lymphoid structures in the quest for novel cancer therapies
This week, explore topics ranging from checkpoint inhibitor therapies to TIRF microscopy and automated liquid chromatography
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
Continued emergence of SARS-CoV-2 variants highlights importance of sequencing for accurate COVID-19 tracking and surveillance
The Simple Plex AAV2 assay combines the scalability and automation of Ella with best-in-class AAV reagents from PROGEN
The company seeks to become a global centre of excellence for whole genome sequencing
Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc. discusses the cutting-edge technology transforming the identification of new targets for the development of effective immunotherapeutics
Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
The drug aims to treat patients with myelodysplastic syndromes
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers
Gain insights on hot topics ranging from respiratory virus testing to nano and quantum materials and automated LC-MS/MS workflows
